Sector News

How big data could revolutionise the healthcare industry

February 19, 2020
Life sciences

We generate data about ourselves all the time, the acquisition and interpretation of which is big business. In many cases, this data may be fairly trivial or inconsequential. In others, this may be the most private and confidential data of all – about our health, for example.

Regardless of what type it falls under, there are businesses out there that will want it.

The question of data in healthcare is timely considering the UK’s exit from the European Union, and the potential for healthcare data to be used as a bargaining chip in future trade deals with the United States and others.

The UK’s National Health Service (NHS) is one of the oldest and most established public healthcare systems in the world. Its practice of tying data to an individual NHS number means its data provides a broader account of patients’ health, and with the NHS increasingly digitising old records, a chronologically longer one too. EY has estimated the data to be worth almost £10bn.

The potential value of that data led to raised eyebrows when, in December, the UK government gave Amazon unfettered access to non-patient data for free, with Amazon’s Alexa voice assistant in turn providing health information via voice search.

Elsewhere, other big tech firms are interested in acquiring medical data, with Google doing a deal with Ascension, a company that runs 2,600 hospitals in the US.

Of course, such data is not purely useful to American tech giants, with the NHS and other health bodies themselves able to capitalise upon it.

One possible avenue of exploration lies in opening up such data sets to AI. The CEO of NHSX, the NHS’s digital transformation arm, Matthew Gould wrote in a recent blog post: “Artificial Intelligence (AI) holds enormous potential for the NHS, if we can use it right. It can reduce the burden on the system by taking on the tasks that can be converted into an algorithm. Many of these are in areas of greatest pressure, like radiography and pathology. It could improve patient outcomes, and increase productivity across the system, freeing up clinicians’ time so they can focus on the parts of the job where they add the most value”

By William Smith

Source: Gigabit

comments closed

Related News

July 3, 2022

Novo Nordisk joins with nursing group to highlight correlation between Type 2 diabetes and cardio risk

Life sciences

Despite atherosclerotic cardiovascular disease (ASCVD) being the leading cause of death for people with Type 2 diabetes, half of those people have no idea of this risk. Novo Nordisk has teamed up with the Preventive Cardiovascular Nurses Association (PCNA) for “Making the Connection,” a program to help increase understanding of the link between the two diseases.

July 3, 2022

First treatment for ‘broken heart syndrome’ trialled

Life sciences

The first ever treatment for broken heart syndrome – also known as Takotsubo cardiomyopathy – is to be trialled by researchers at the University of Aberdeen. Scientists will trial a programme of exercise conditioning and psychological therapy for people who have been diagnosed with the condition following a £300,000 grant from the British Heart Foundation.

July 3, 2022

Nestlé acquiring The Better Health Company in market expansion deal

Life sciences

Nestlé Health Science is set to acquire The Better Health Company (TBHC), as part of its goals to grow global market share while spurring innovation across the nutrition industry. The acquisition includes the GO Healthy brand with its vitamins and supplements, Egmont, the Manuka honey brand and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins minerals and supplements.